Information
INVESTORS
Stemedica Cell Technologies, Inc. ("Stemedica") is a specialty biopharmaceutical company that develops, manufactures and distributes best-in-class adult stem cell products. The Company’s products are used for clinical applications internationally and in research studies in the United States following FDA guidelines.
Stemedica believes its multiple cell technology and condition-specific protocols provide the Company with a strategic advantage over single cell approaches in treating complex medical diseases and conditions.
Stemedica Cell Technologies Inc. is a privately held company. For more information regarding the Company, please contact:
Investor Relations
Stemedica Cell Technologies, Inc
5375 Mira Sorrento Place Suite 100
San Diego, CA 92121
Investors@Stemedica.com
858-658-0910 x 333